Table I. Comparison of murine, canine and human platelets and canine and murine ITP model systems.
Humans | Mice | Dogs | |
---|---|---|---|
Spontaneous ITP? | Yes | No (Semple, 2010) | Yes (Lewis & Meyers, 1996) |
Platelet counts | 150-400 × 109/l | 1 million/μl (Ware, 2004) | 190-468 × 109/l |
Platelet volumes | 7.5-10 fl | 4.7 ± 0.3 fl(Ware, 2004) | 7.9-13.8 fl |
Platelet protease activated-receptors (PAR) | PAR 1 and 4 (Ware, 2004) | PAR 3 and 4 (Ware, 2004) | PAR 1 and 4 (Boudreaux et al, 2007) |
Blood volume that can be safely sampled | N/A | 0.2 ml (Diehl et al, 2001) (25 g mouse) | 85 ml (Diehl et al, 2001) (10 kg dog) |
Animal survival studies possible? | N/A | No | Yes |
Result of ITP models utilizing antibodies to the fibrinogen receptor (GPIIbIIIa) | Variable bleeding, no systemic symptoms other than fatigue (with spontaneous disease) | Acute systemic reactions, hypothermia, incoordination (Nieswandt et al, 2000) | Variable bleeding, no systemic signs other than those relating to haemorrhage (Lewis & Meyers, 1996; O'Marra et al, 2011) |
ITP, immune thrombocytopenia; GPIIbIIIa, glycoprotein IIbIIIa complex; N/A, not applicable.